PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases the boston puerto rican health study

Diabetes

Volumn 57, Issue 4, 2008, Pages 809-816

  Lai, Chao Qiang ^a   Tucker, Katherine L ^a   Parnell, Laurence D ^a   Adiconis, Xian ^a   García Bailo, Bibiana ^a   Griffith, John ^b   Meydani, Mohsen ^a   Ordováls, José M ^a  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8-HYDROXY-2'-DEOXYGUANOSINE; BIOLOGICAL MARKER; DEOXYGUANOSINE; DRUG DERIVATIVE; HEAT SHOCK PROTEIN; PPARGC1A PROTEIN, HUMAN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE COURSE; DNA DAMAGE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA GENE; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PUERTO RICO; SELF REPORT; URINARY EXCRETION; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ETHNOLOGY; EXON; GENE FREQUENCY; GENETICS; INTRON; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; URINE;

ADULT; AGED; BIOLOGICAL MARKERS; BOSTON; CARDIOVASCULAR DISEASES; DEOXYGUANOSINE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DNA DAMAGE; EXONS; FEMALE; GENE FREQUENCY; HEAT-SHOCK PROTEINS; HUMANS; INTRONS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PUERTO RICO; RISK FACTORS; TRANSCRIPTION FACTORS; VARIATION (GENETICS);

EID: 42449113349     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1238     Document Type: Article

References (50)

1. Zimmet P: Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted? J Intern Med 247:301-310, 2000
2. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T: Oxidative damage to DNA in diabetes mellitus. Lancet 347: 444-445, 1996
3. Shigenaga MK, Gimeno CJ, Ames BN: Urinary 8-hydroxy-2′-deox- yguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA 86:9697-9701, 1989
4. Lowell BB, Shulman GI: Mitochondrial dysfunction and type 2 diabetes. Science 307:384-387, 2005
5. Lenaz G, Bovina C, D'Aurelio M, Fato R, Formiggini G, Genova ML, Giuliano G, Merlo Pich M, Paolucci U, Parenti Castelli G, Ventura B: Role of mitochondria in oxidative stress and aging. Ann N Y Acad Sci 959:199-213, 2002
6. Miwa S, Brand MD: Mitochondrial matrix reactive oxygen species production is very sensitive to mild uncoupling. Biochem Soc Trans 31:1300-1301, 2003
7. Takatori A, Ishii Y, Itagaki SI, Kyuwa S, Yoshikawa Y: Amelioration of the β-cell dysfunction in diabetic APA hamsters by antioxidants and AGE inhibitor treatments. Diabete Metab Res Rev 20:211-218, 2004
8. Lin J, Handschin C, Spiegelman BM: Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1:361-370, 2005
9. Handschin C, Spiegelman BM: Peroxisome proliferator-activated receptor coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 27:728-735, 2006
10. Finck BN, Kelly DP: PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 116:615-622, 2006
11. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM: A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829-839, 1998
12. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM: Mechanisms controllingmitochondrial biogenesis and respiration through the thermogenic coacti-vator PGC-1. Cell 98:115-124, 1999
13. St-Pierre J, Lin J, Krauss S, Tarr PT, Yang R, Newgard CB, Spiegelman BM: Bioenergetic analysis of peroxisome proliferators activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem 278:26597-26603, 2003
14. Pilegaard H, Saltin B, Neufer PD: Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle. J Physiol 546:851-858, 2003
15. Norrbom J, Sundberg CJ, Ameln H, Kraus WE, Jansson E, Gustafsson T: PGC-1a mRNA expression is influenced by metabolic perturbation in exercising human skeletal muscle. J Appl Physiol 96:189-194, 2004
16. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, Spiegelman BM: Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127:397-408, 2006
17. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC: PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267-273, 2003
18. Franks PW, Loos RJ: PGC-1alpha gene and physical activity in type 2 diabetes mellitus. Exerc Sport Sci Rev 34:171-175, 2006
19. Ling C, Poulsen P, Carlsson E, Ridderstrale M, Almgren P, Wojtaszewski J, Beck-Nielsen H, Groop L, Vaag A: Multiple environmental and genetic factors influence skeletal muscle PGC-1 a and PGC-1β gene expression in twins. J Clin Invest 114:1518-1526, 2004
20. Ek J, Andersen G, Urhammer SA, Gæde PH, Drivsholm T, Borch-Johnsen K, Hansen T, Pedersen O: Mutation analysis of peroxisome proliferators activated receptor-a coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus. Diabetologia 44:2220-2226, 2001
21. Hara KK, Tobe K, Okada T, Kadowaki H, Akanuma Y, Ito C, Kimura S, Kadowaki T: A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to type II diabetes. Diabetologia 45:740-743, 2002
22. Barroso I, Luan J, Middelberg RP, Harding AH, Franks PW, Jakes RW, Clayton D, Schafer AJ, O'Rahilly S, Wareham NJ: Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action. PLoS Biol 1:41-55, 2003
23. Oberkofler H, Linnemayr V, Weitgasser R, Klein K, Xie M, Iglseder B, Krempler F, Paulweber B, Patsch W: Complex haplotypes of the PGC-1a gene are associated with carbohydrate metabolism and type 2 diabetes. Diabetes 53:1385-1393, 2004
24. Barroso I, Luan J, Sandhu MS, Franks PW, Crowley V, Schafer AJ, O'Rahilly S, Wareham NJ: Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia 49:501-505, 2006
25. Kunej T, Globo M, Petrovi NIK, Dov P, Peterlin B, Petrovi D: A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-γ coacti-vator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians. Folia Biologica (Praha) 50:157-158, 2004
26. Choi YS, Hong JM, Lim S, Ko KS, Pak YK: Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor coactiva-tor-1a (PGC-1a) on mitochondrial transcription factor A (Tfam) promoter. Biochem Biophys Res Commun 344:708-712, 2006
27. Andrulionyte L, Peltola P, Chiasson JL, Laakso M, for the STOP-NIDDM Study Group: Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes the STOP-NIDDM Trial. Diabetes 55:2148-2152, 2006
28. Tucker KL: Stress and nutrition in relation to excess development of chronic disease in Puerto Rican adults living in the Northeastern USA. J Med Invest 52 (Suppl.):252-258, 2005
29. Ho GYF, Qian H, Kim MY, Melnik TA, Tucker KL, Jimenez-Velazquez IZ, Kaplan RC, Lee-Rey ET, Stein DT, Rivera W, Rohan TE: Health disparities between island and mainland Puerto Ricans. Pan Am J Public Health 19:331-339, 2006
30. American Diabetes Association: Standards of medical care in diabetes 2007. Diabetes Care, 30 (Suppl. 1):S4-S41, 2007
31. Lee IM, Paffenbarger RS Jr: Physical activity and stroke incidence: the Harvard Alumni Health Study. Stroke 29:2049-2054,1998
32. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D: Efficiency and power in genetic association studies. Nat Genet 37:1217-1223, 2005
33. Matys V, Fricke E, Geffers R, Goessling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-Margoulis OV, Kloos DU, Land S, Lewicki-Potapov B, Michael H, Muench R, Reuter I, Rotert S, Saxel H, Scheer M, Thiele S, Wingender E: TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acid Res 31:374-378, 2003
34. Livak KJ: Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14:143-149, 1999
35. Box GEP, Cox DR: An analysis of transformations. J R Stat Soc Series B 26:211-252, 1964
36. Excoffier L, Slatkin M: Maximum-likelihood estimation of molecular hap-lotype frequencies in a diploid population. Mol Biol Evol 12:921-927, 1995
37. HelixTree Manual, Version 5.3.0, released 5 April 2007. Available from http://www.goldenhelix.com/.
38. Falush D, Stephens M, Pritchard JK: Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164:1567-1587, 2003
39. Yu Z, Schaid DJ: Sequential haplotype scan methods for association analysis. Genet Epidemiol 31:553-564, 2007
40. Korshunov SS, Skulachev VP, Starkov AA: High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 416:15-18, 1997
41. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625, 2005
42. Park KS, Kim JH, Kim MS, Kim JM, Kim SK, Choi JY, Chung MH, Han B, Kim SY, Lee HK: Effects of insulin and antioxidant on plasma 8-hydrox-yguanine and tissue 8-hydroxydeoxyguanosine in streptozotocin-induced diabetic rats. Diabetes 50:2837-2841, 2001
43. Pyorala K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: an epidemiologic view. Diabetes 3:463-524, 1987
44. Bierman EL: Atherogenesis in diabetes. Arterioscler Thromb 12:647-656, 1992
45. Andreassi MG, Botto N: DNA damage as a new emerging risk factor in atherosclerosis. Trends Cardiovasc Med 13:270-275, 2003
46. Devaraj S, Jialal I: Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications-the effect of a-tocopherol supplementation. Circulation 102:191-196, 2000
47. Kim JA, Berliner JA, Natarajan RD, Nadler JL: Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes 43:1103-1107, 1994
48. Hoogerbrugge N, Verkerk A, Jacobs ML, Postema PT, Jongkind JF: Hypertriglyceridemia enhances monocyte binding to endothelial cells in NIDDM. Diabetes Care 3:1122-1124, 1997
49. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM: Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106:927-932, 2002
50. Sriwijitkamol A, Coletta DK, Wajcberg E, Balbontin GB, Reyna SM, Barrientes J, Eagan PA, Jenkinson CP, Cersosimo E, DeFronzo RA, Sakamoto K, Musi N: Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study. Diabetes 56:836-848, 2007